Seer Inc (SEER) USD0.00001 A

Sell:$2.00Buy:$2.35$0.03 (1.31%)

NASDAQ:2.20%
Market closed | Prices delayed by at least 15 minutes
Sell:$2.00
Buy:$2.35
Change:$0.03 (1.31%)
Market closed | Prices delayed by at least 15 minutes
Sell:$2.00
Buy:$2.35
Change:$0.03 (1.31%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution that includes consumables, an automation instrument and software. Its proprietary engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide-level, including protein variants. It is focused on driving the adoption of the Proteograph by customers in the proteomics and genomics markets. The Proteograph Product Suite is an integrated solution consisting of consumables, an automation instrument, and software to perform biased, deep proteomic analysis at scale in a matter of hours.

Key people

Omid C. Farokhzad
Chairman of the Board, Chief Executive Officer, Co-Founder
David R. Horn
President, Chief Financial Officer, Treasurer
Nicolas Henry Roelofs
Lead Independent Director
Robert S. Langer
Director
Meeta Gulyani
Independent Director
David L. Hallal
Independent Director
Terrance G. Mcguire
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Technology
  • Industry
    Scientific & Technical Instr.
  • ISIN
    US81578P1066
  • Market cap
    $137.98m
  • Employees
    147
  • Shares in issue
    54.92m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.